Skip to main content
Clinical Trials/NCT04109326
NCT04109326
Completed
N/A

Effect of a Tailored Program of Physical Activity and Nutritional Therapeutic Education on Clinical, Psychological and Sociological Factors in Breast Cancer Patients Undergoing Adjuvant Treatment : Multicenter Randomized Controlled Trial

Institut du Cancer de Montpellier - Val d'Aurelle8 sites in 1 country360 target enrollmentMay 15, 2013
ConditionsBreast Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Enrollment
360
Locations
8
Primary Endpoint
Rate of cancer-related fatigue
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This multicenter randomized controlled trial aims to evaluate the effect of a tailored program of physical activity and nutritional therapeutic education on clinical, psychological and sociological factors in breast cancer patients undergoing adjuvant treatment.

Detailed Description

The experimental arm "APAD": tailored PA program associated with individual nutritional counseling whilst hospitalization and at home during the 26-week duration of adjuvant treatment The experimental program will include: * 8 PA sessions supervised at the hospital centers and 44 unsupervised home sessions, to be performed twice a week. * 6 consultations for nutrition education to teach the principles of well balanced diet, to foster weigh control during treatment, and to induce appropriate feeding behaviors after treatment. The control arm: standard of care

Registry
clinicaltrials.gov
Start Date
May 15, 2013
End Date
June 11, 2016
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female patient with histologically proven breast cancer
  • Age ≥18 years old
  • Patients having undergone curative surgery and eligible to 6 cycles of adjuvant chemotherapy (6 FEC100, or 3FEC100 + 3 taxanes) followed by radiotherapy
  • Satisfactory healing from surgical act on breast and lymph nodes
  • Ability to understand the nature, goal and study methodology
  • Consent to cooperate for clinical assessments
  • Affiliation to a social security regime or beneficiary of equivalent social protection
  • Written informed consent provided before any study specific procedures

Exclusion Criteria

  • Metastatic disease
  • Any other primary tumor
  • Contra-indication to moderate physical activity: Unchecked high blood pressure; family history of sudden death in a first degree relative; not stabilized heart disease; acute or chronic lung disease resulting in dyspnea for moderate effort; uncontrolled diabetes, carrying a stent; other severe pathologies unstabilized, disabled or not indicated to physical practice.
  • Contra-indication to adjuvant chemotherapy or radiotherapy
  • Pregnancy or breast feeding (according to the recommendations of the usual adjuvant breast cancer)
  • Inability to attend or comply with interventions or follow-up scheduling, disability or difficulty preventing a proper understanding of trial instructions
  • Legal inability or restricted legal ability

Outcomes

Primary Outcomes

Rate of cancer-related fatigue

Time Frame: 6 months

The primary assessment criterion is subjective fatigue measured using the 'General Fatigue' subscale of the Multidimensional Fatigue Inventory (MFI-20) questionnaire.

Study Sites (8)

Loading locations...

Similar Trials